Palisade Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Buy
119,278
+8,596
+8% +$752K 1.01% 35
2026
Q1
$9.43M Sell
110,682
-7,311
-6% -$652K 0.95% 36
2025
Q4
$9.32M Sell
117,993
-1,038
-0.9% -$81.4K 0.91% 36
2025
Q3
$9.52M Sell
119,031
-2,528
-2% -$216K 0.88% 38
2025
Q2
$11M Buy
121,559
+20
+0% +$1.83K 1.1% 34
2025
Q1
$11.4M Buy
121,539
+30
+0% +$2.69K 1.17% 31
2024
Q4
$11M Buy
121,509
+435
+0.4% +$41.5K 1.12% 32
2024
Q3
$12.6M Sell
121,074
-2,003
-2% -$204K 1.23% 29
2024
Q2
$11.9M Sell
123,077
-636
-0.5% -$58.7K 1.24% 27
2024
Q1
$11.1M Buy
123,713
+909
+0.7% +$77K 1.09% 32
2023
Q4
$9.79M Buy
122,804
+6,772
+6% +$509K 1.07% 34
2023
Q3
$8.25M Buy
116,032
+1,642
+1% +$123K 1% 35
2023
Q2
$8.81M Buy
114,390
+3,165
+3% +$245K 1.02% 34
2023
Q1
$8.36M Buy
111,225
+1,224
+1% +$91K 1.02% 35
2022
Q4
$8.67M Buy
110,001
+2,701
+3% +$203K 0.99% 35
2022
Q3
$7.54M Buy
107,300
+2,434
+2% +$191K 1.03% 34
2022
Q2
$8.4M Buy
104,866
+3,480
+3% +$272K 1.08% 32
2022
Q1
$7.69M Buy
101,386
+4,821
+5% +$382K 0.88% 41
2021
Q4
$8.24M Buy
96,565
+1,822
+2% +$142K 0.92% 37
2021
Q3
$7.16M Buy
94,743
+5,303
+6% +$421K 0.87% 44
2021
Q2
$7.28M Buy
89,440
+200
+0.2% +$16.4K 0.86% 42
2021
Q1
$7.04M Sell
89,240
-475
-0.5% -$37.2K 0.91% 40
2020
Q4
$7.67M Sell
89,715
-304
-0.3% -$25.1K 1.04% 34
2020
Q3
$6.95M Sell
90,019
-1,385
-2% -$106K 1.05% 33
2020
Q2
$6.7M Sell
91,404
-575
-0.6% -$40.8K 1.07% 34
2020
Q1
$6.1M Sell
91,979
-290
-0.3% -$20.5K 1.11% 32
2019
Q4
$6.35M Sell
92,269
-62
-0.1% -$4.23K 0.93% 42
2019
Q3
$6.79M Sell
92,331
-260
-0.3% -$18.9K 1.03% 40
2019
Q2
$6.64M Buy
92,591
+90
+0.1% +$6.39K 1.03% 40
2019
Q1
$6.34M Sell
92,501
-54,525
-37% -$3.52M 1% 39
2018
Q4
$8.75M Buy
147,026
+5,416
+4% +$339K 1.28% 35
2018
Q3
$9.48M Buy
141,610
+795
+0.6% +$53K 1.25% 36
2018
Q2
$9.13M Buy
140,815
+8,100
+6% +$530K 1.32% 35
2018
Q1
$9.51M Buy
132,715
+23,981
+22% +$1.73M 1.44% 33
2017
Q4
$8.2M Buy
108,734
+11,100
+11% +$810K 1.3% 32
2017
Q3
$7.11M Buy
97,634
+1,820
+2% +$131K 1.29% 32
2017
Q2
$7.1M Sell
95,814
-30
-0% -$2.23K 1.39% 32
2017
Q1
$7.01M Sell
95,844
-384
-0.4% -$26.9K 1.29% 33
2016
Q4
$6.3M Sell
96,228
-5,353
-5% -$367K 1.21% 32
2016
Q3
$7.53M Sell
101,581
-200
-0.2% -$14.8K 1.4% 29
2016
Q2
$7.45M Sell
101,781
-675
-0.7% -$48.1K 1.41% 28
2016
Q1
$7.24M Buy
102,456
+1,883
+2% +$125K 1.4% 27
2015
Q4
$6.7M Sell
100,573
-1,400
-1% -$93.1K 1.44% 28
2015
Q3
$6.47M Sell
101,973
-9,500
-9% -$621K 1.45% 25
2015
Q2
$7.29M Buy
111,473
+533
+0.5% +$36.2K 1.45% 27
2015
Q1
$7.69M Sell
110,940
-1,950
-2% -$135K 1.51% 26
2014
Q4
$7.81M Hold
112,890
1.54% 28
2014
Q3
$7.36M Sell
112,890
-4,550
-4% -$300K 1.51% 30
2014
Q2
$8.01M Sell
117,440
-100
-0.1% -$6.7K 1.68% 25
2014
Q1
$7.63M Buy
117,540
+8,150
+7% +$514K 1.67% 25
2013
Q4
$7.13M Buy
109,390
+700
+0.6% +$44.8K 1.62% 25
2013
Q3
$6.45M Buy
108,690
+400
+0.4% +$23.7K 1.64% 24
2013
Q2
$6.2M Buy
+108,290
New +$6.43M 1.56% 29

Other funds holding CL

Palisade Asset Management's CL Position: Q2 2026 in Review

Palisade Asset Management increased its Colgate-Palmolive (CL) stake by 7.8% in Q2 2026, buying an estimated $752K and bringing the position to 119,278 shares worth $10.9M. The position accounts for 1.01% of the portfolio, ranked #35.

Palisade Asset Management first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.6M in Q3 2024. 536 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Palisade Asset Management held 119,278 shares of Colgate-Palmolive worth $10.9M as of Q2 2026.
  • Palisade Asset Management bought 8,596 Colgate-Palmolive shares in Q2 2026, an estimated $752K.
  • Colgate-Palmolive made up 1.01% of Palisade Asset Management's portfolio in Q2 2026, its #35 holding.
  • Palisade Asset Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Palisade Asset Management's Colgate-Palmolive position peaked at $12.6M in Q3 2024.
  • 536 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.